New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy
Around 0.75 million babies worldwide suffer from moderate or severe hypoxic-ischemic
encephalopathy (HIE) each year resulting in around 400,000 babies with …
encephalopathy (HIE) each year resulting in around 400,000 babies with …
Advances in therapies to treat neonatal hypoxic-ischemic encephalopathy
Neonatal hypoxic-ischemic encephalopathy (HIE) is a condition that results in brain damage
in newborns due to insufficient blood and oxygen supply during or after birth. HIE is a major …
in newborns due to insufficient blood and oxygen supply during or after birth. HIE is a major …
Hypoxic-ischemic encephalopathy: pathogenesis and promising therapies
M Yang, K Wang, B Liu, Y Shen, G Liu - Molecular neurobiology, 2024 - Springer
Hypoxic-ischemic encephalopathy (HIE) is a brain lesion caused by inadequate blood
supply and oxygen deprivation, often occurring in neonates. It has emerged as a grave …
supply and oxygen deprivation, often occurring in neonates. It has emerged as a grave …
Human umbilical cord blood mononuclear cells transplantation for perinatal brain injury
Y Xi, G Yue, S Gao, R Ju, Y Wang - Stem Cell Research & Therapy, 2022 - Springer
Perinatal brain injury is a leading cause of death and disability in children. Hypoxic-ischemic
encephalopathy in full term infants, and white matter injury in premature infants are most …
encephalopathy in full term infants, and white matter injury in premature infants are most …
A pilot phase i trial of allogeneic umbilical cord tissue-derived mesenchymal stromal cells in neonates with hypoxic-ischemic encephalopathy
CM Cotten, K Fisher, W Malcolm… - Stem Cells …, 2023 - academic.oup.com
Hypoxic ischemic encephalopathy (HIE) in neonates causes increased mortality and long-
term morbidity in surviving babies. Hypothermia (HT) has improved outcomes, however …
term morbidity in surviving babies. Hypothermia (HT) has improved outcomes, however …
[HTML][HTML] A narrative review on treatment strategies for neonatal hypoxic ischemic encephalopathy
JM Korf, LD McCullough, V Caretti - Translational Pediatrics, 2023 - ncbi.nlm.nih.gov
Methods We included full articles and book chapters published in English on PubMed with
references to “hypoxic ischemic encephalopathy”,“birth asphyxia”,“therapeutic hypothermia” …
references to “hypoxic ischemic encephalopathy”,“birth asphyxia”,“therapeutic hypothermia” …
Neonatal asphyxia as an inflammatory disease: reactive oxygen species and cytokines
K Okazaki, S Nakamura, K Koyano, Y Konishi… - Frontiers in …, 2023 - frontiersin.org
Neonatologists resuscitate asphyxiated neonates by every available means, including
positive ventilation, oxygen therapy, and drugs. Asphyxiated neonates sometimes present …
positive ventilation, oxygen therapy, and drugs. Asphyxiated neonates sometimes present …
The potential of mesenchymal stromal cell as therapy in neonatal diseases
Mesenchymal stromal cells (MSCs) can be derived from various tissue sources, such as the
bone marrow (BMSCs), adipose tissue (ADSCs), umbilical cord (UC-MSCs) and umbilical …
bone marrow (BMSCs), adipose tissue (ADSCs), umbilical cord (UC-MSCs) and umbilical …
Mesenchymal stem cell therapy in perinatal arterial ischemic stroke: systematic review of preclinical studies
V Lehnerer, A Roidl, O Romantsik, R Guzman… - Pediatric …, 2024 - nature.com
Background Perinatal arterial ischemic stroke (PAIS) is a neurologic disorder leading to long-
term complications. Mesenchymal stem cells (MSCs) have emerged as a novel therapeutic …
term complications. Mesenchymal stem cells (MSCs) have emerged as a novel therapeutic …
Stem cell therapy for diabetic foot ulcers: Theory and practice
DL Nalisa, M Moneruzzaman… - Journal of Diabetes …, 2022 - Wiley Online Library
Diabetic foot ulcers are associated with increases in limb amputation, morbidity, and
mortality. Recently, a stem cell application is emerging as promising adjuvant therapy. We …
mortality. Recently, a stem cell application is emerging as promising adjuvant therapy. We …